International Clinical Trial: Scientific title A randomized controlled study to evaluate the safety and efficacy of Yukeshu medical recombinant collagen gel in patients with pathological scars after surgery combined with radiotherapy

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131459) titled 'Scientific title A randomized controlled study to evaluate the safety and efficacy of Yukeshu medical recombinant collagen gel in patients with pathological scars after surgery combined with radiotherapy' on Sept. 2.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine

Condition: Pathological scars

Intervention: Experimental group:Yukeshu Medical Recombinant Collagen Gel

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-07

Target Sample Size: Experimental group:20;Control g...